1-amino-1,3-dicarboxycyclopentane has been researched along with Sclerosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clusmann, H; Dietrich, D; Friedl, M; Kral, T; Schramm, J | 1 |
1 other study(ies) available for 1-amino-1,3-dicarboxycyclopentane and Sclerosis
Article | Year |
---|---|
Reduced function of L-AP4-sensitive metabotropic glutamate receptors in human epileptic sclerotic hippocampus.
Topics: Action Potentials; Adult; Aminobutyrates; Cycloleucine; Dentate Gyrus; Electrophysiology; Epilepsy, Temporal Lobe; Excitatory Amino Acid Antagonists; Humans; Neuroprotective Agents; Perforant Pathway; Propionates; Receptors, Metabotropic Glutamate; Sclerosis; Synaptic Transmission | 1999 |